Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integrated BiopharmaINBP 36 Days Inventory is 72.43 as of Mar. 2026, which is 2% below its 10-year median of 74.27. GuruFocus rates INBP with a GF Score™ of 36/100 and a GF Value™ of $0.26 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 1,874 Consumer Packaged Goods companies, Integrated Biopharma ranks better than 56.88% on this metric.
The historical rank and industry rank for Integrated Biopharma's Days Inventory or its related term are showing as below:
INBP'
s Days Inventory Range Over the Past 10 Years
Min: 67.28 Med: 74.27 Max: 84.52
Current: 73.6
During the past 13 years, Integrated Biopharma's highest Days Inventory was 84.52. The lowest was 67.28. And the median was 74.27.
INBP's Days Inventory is ranked better than 56.88% of 1874
companies
in the Consumer Packaged Goods industry
Industry Median: 83.04
vs INBP: 73.60
Integrated Biopharma's Days Inventory
declined
from Mar. 2025 (77.82) to Mar. 2026 (72.43).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Integrated Biopharma's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.26.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integrated Biopharma's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.82.
Integrated Biopharma (OTCPK:INBP) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Integrated Biopharma's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Integrated Biopharma's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Integrated Biopharma Days Inventory Related Terms
Integrated Biopharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Integrated Biopharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
INBP vs HCWC, PAVS, BABB: Days Inventory Comparison
For the Packaged Foods subindustry, Integrated Biopharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Biopharma Days Inventory vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Integrated Biopharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Integrated Biopharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Integrated Biopharma (INBP) has a Days Inventory of 72.43 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integrated Biopharma and its competitors. This is near median its historical median of 74.27. Over the past decade, Integrated Biopharma's Days Inventory has ranged from 67.28 to 84.52. According to the industry distribution chart, Integrated Biopharma ranks #808 out of 1874 companies in the Consumer Packaged Goods industry, placing it in the top 43.1%.
Is Integrated Biopharma's Days Inventory too high?
Integrated Biopharma's current Days Inventory of 72.43 is near median its 10-year median of 74.27. Over the past 10 years, this metric has ranged from a low of 67.28 to a high of 84.52. The Consumer Packaged Goods industry median Days Inventory is 83.04. Integrated Biopharma's value of 72.43 is 12.8% below this industry median. Based on the distribution chart, Integrated Biopharma ranks #808 out of 1874 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Integrated Biopharma has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrated Biopharma's Days Inventory compare to HCWC and PAVS?
According to the Consumer Packaged Goods industry distribution chart, Integrated Biopharma ranks #808 out of 1874 companies for Days Inventory. This puts Integrated Biopharma in the upper half of its industry. The industry median Days Inventory is 83.04. Integrated Biopharma's value of 72.43 is 12.8% below this benchmark. Historically, Integrated Biopharma's own Days Inventory has ranged from 67.28 to 84.52 over the past decade. While the company's 10-year median is 74.27 vs. the industry median of 83.04, Integrated Biopharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Consumer Packaged Goods company?
The median Days Inventory among Consumer Packaged Goods companies is 83.04, based on 1,874 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Biopharma's current Days Inventory of 72.43 is 12.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Integrated Biopharma and its competitors. For the Consumer Packaged Goods industry, the median Days Inventory is 83.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Biopharma's current Days Inventory is 72.43, which is near median its own 10-year median of 74.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Biopharma stock overvalued right now?
Based on GuruFocus' analysis, Integrated Biopharma (INBP) is currently considered Possible Value Trap. The stock's GF Value™ is $0.26, compared to a current price of $0.16 — trading 38.5% below its estimated fair value. The current Days Inventory is 72.43, which is near median its 10-year median of 74.27 and 12.8% below the Consumer Packaged Goods industry median of 83.04. Integrated Biopharma's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Integrated Biopharma (INBP), the current Days Inventory is 72.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Biopharma (INBP) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Biopharma stock appears to be undervalued.
The current stock price of $0.16 is trading 38.5% below its estimated GF Value™ of $0.26.
GuruFocus considers Integrated Biopharma to be Possible Value Trap.
Key valuation signals for INBP:
Days Inventory: 72.43 (near median its 10-year median of 74.27)
GF Value™: $0.26 vs. price of $0.16 (38.5% below fair value)
Industry Position: 12.8% below the Consumer Packaged Goods median (#808 of 1874)
No single metric tells the full story. See the INBP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Biopharma Inc is a pharmaceutical company engaged in manufacturing, distributing, marketing, and selling vitamins, nutritional supplements, and herbal products. It operates in two segments: Contract Manufacturing and Other Nutraceutical Businesses. Key revenue is generated from the Contract Manufacturing segment, which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
36GF Score
Get the complete analysis for INBP
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INBP has been successfully added to your 
